HUP0004306A3 - Benzamidine derivatives as factor xa inhibitors and process for their preparation - Google Patents
Benzamidine derivatives as factor xa inhibitors and process for their preparationInfo
- Publication number
- HUP0004306A3 HUP0004306A3 HU0004306A HUP0004306A HUP0004306A3 HU P0004306 A3 HUP0004306 A3 HU P0004306A3 HU 0004306 A HU0004306 A HU 0004306A HU P0004306 A HUP0004306 A HU P0004306A HU P0004306 A3 HUP0004306 A3 HU P0004306A3
- Authority
- HU
- Hungary
- Prior art keywords
- inhibitors
- factor
- preparation
- benzamidine derivatives
- benzamidine
- Prior art date
Links
- 229940123583 Factor Xa inhibitor Drugs 0.000 title 1
- 150000003937 benzamidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Quinoline Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19743435A DE19743435A1 (de) | 1997-10-01 | 1997-10-01 | Benzamidinderivate |
| PCT/EP1998/005898 WO1999016751A1 (de) | 1997-10-01 | 1998-09-16 | Benzamidinderivate als faktor xa-inhibitoren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0004306A2 HUP0004306A2 (hu) | 2001-11-28 |
| HUP0004306A3 true HUP0004306A3 (en) | 2001-12-28 |
Family
ID=7844313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0004306A HUP0004306A3 (en) | 1997-10-01 | 1998-09-16 | Benzamidine derivatives as factor xa inhibitors and process for their preparation |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6492368B1 (hu) |
| EP (1) | EP1025086B1 (hu) |
| JP (1) | JP2001518467A (hu) |
| KR (1) | KR20010024386A (hu) |
| CN (1) | CN1272107A (hu) |
| AR (1) | AR017164A1 (hu) |
| AT (1) | ATE243681T1 (hu) |
| AU (1) | AU736080B2 (hu) |
| BR (1) | BR9812699A (hu) |
| CA (1) | CA2305568A1 (hu) |
| DE (2) | DE19743435A1 (hu) |
| HU (1) | HUP0004306A3 (hu) |
| ID (1) | ID24430A (hu) |
| NO (1) | NO20001687D0 (hu) |
| PL (1) | PL339173A1 (hu) |
| RU (1) | RU2194044C2 (hu) |
| SK (1) | SK282799B6 (hu) |
| WO (1) | WO1999016751A1 (hu) |
| ZA (1) | ZA988937B (hu) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE314347T1 (de) | 1997-09-30 | 2006-01-15 | Daiichi Seiyaku Co | Sulfonylderivate |
| GB9809349D0 (en) * | 1998-05-02 | 1998-07-01 | Zeneca Ltd | Heterocyclic derivatives |
| BR9910179A (pt) * | 1998-05-02 | 2001-01-09 | Astrazeneca Ab | Composto, composição farmacêutica, uso de um composto, e, processo para tratar uma doença ou condição mediada por fator xa em um animal de sangue quente |
| CA2340100A1 (en) * | 1998-08-11 | 2000-02-24 | Daiichi Pharmaceutical Co., Ltd. | Novel sulfonyl derivatives |
| EP1088821A1 (en) | 1999-09-28 | 2001-04-04 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives |
| EP1829535A3 (en) * | 1999-10-27 | 2007-10-24 | Tanox, Inc. | Tissue factor antagonists and methods of use thereof |
| US6608066B1 (en) * | 1999-10-27 | 2003-08-19 | Sunol Molecular Corporation | Tissue factor antagonists and methods of use thereof |
| DE10035928A1 (de) | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| DE10035927A1 (de) | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| EP1193267A1 (en) * | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein JunKinases |
| EP1193256A1 (en) * | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins |
| EP1193268A1 (en) * | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
| JP4564713B2 (ja) | 2000-11-01 | 2010-10-20 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | 窒素性複素環式化合物、ならびに窒素性複素環式化合物およびその中間体を作製するための方法 |
| DE10102322A1 (de) | 2001-01-19 | 2002-07-25 | Merck Patent Gmbh | Phenylderivate |
| DE10130718A1 (de) * | 2001-06-26 | 2003-01-02 | Merck Patent Gmbh | Kohlenhydratderivate |
| AU2003218738B2 (en) | 2002-03-13 | 2009-01-08 | Janssen Pharmaceutica N.V. | Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| BR0308081A (pt) | 2002-03-13 | 2004-12-21 | Janssen Pharmaceutica Nv | Inibidores de histona desacetilase |
| DK1569912T3 (en) | 2002-12-03 | 2015-06-29 | Pharmacyclics Inc | 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors. |
| TW200633990A (en) | 2004-11-18 | 2006-10-01 | Takeda Pharmaceuticals Co | Amide compound |
| NZ555770A (en) * | 2004-12-24 | 2010-12-24 | Astrazeneca Ab | Heterocyclic piperazine-carboxamide compounds as CCR2B antagonists |
| WO2007007588A1 (ja) * | 2005-07-08 | 2007-01-18 | Ono Pharmaceutical Co., Ltd. | 平面性を有する環状基を母核とする化合物 |
| WO2007070506A2 (en) * | 2005-12-14 | 2007-06-21 | Amgen Inc. | Diaza heterocyclic sulfonamide derivatives and their uses |
| US7750012B2 (en) | 2005-12-21 | 2010-07-06 | Decode Genetics Ehf | Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammation |
| GB0525957D0 (en) | 2005-12-21 | 2006-02-01 | Astrazeneca Ab | Methods |
| US8877791B2 (en) | 2006-08-04 | 2014-11-04 | Beth Israel Deaconess Medical Center, Inc. | Inhibitors of pyruvate kinase and methods of treating disease |
| JP5464709B2 (ja) | 2007-06-08 | 2014-04-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ピペリジン／ピペラジン誘導体 |
| ES2558152T3 (es) * | 2007-06-08 | 2016-02-02 | Janssen Pharmaceutica, N.V. | Derivados de piperidina/piperazina |
| JO2972B1 (en) | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine / piperazine derivatives |
| CA2687754C (en) | 2007-06-08 | 2015-12-08 | Janssen Pharmaceutica N.V. | Piperidine, piperazine derivatives for use as dgat inhibitors |
| CA2696609C (en) | 2007-08-27 | 2017-09-05 | Helicon Therapeutics, Inc. | Therapeutic isoxazole compounds |
| RU2480458C2 (ru) * | 2007-09-07 | 2013-04-27 | Тереванс, Инк. | Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов |
| JP5319536B2 (ja) * | 2007-09-21 | 2013-10-16 | Ｍｓｄ株式会社 | ４−スルホニルピペリジン誘導体 |
| UY31863A (es) * | 2008-06-05 | 2010-01-05 | Janssen Pharmaceutica Nv | Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar |
| US20100152197A1 (en) * | 2008-12-15 | 2010-06-17 | Astrazeneca Ab | (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives |
| MX2011008885A (es) | 2009-02-26 | 2011-09-29 | Reviva Pharmaceuticals Inc | Composiciones, sintesis y metodos para usar derivados de arilpiperazina. |
| CN102448951B (zh) | 2009-04-06 | 2017-05-10 | 安吉奥斯医药品有限公司 | 丙酮酸激酶m2调节剂、治疗组合物和相关使用方法 |
| IN2012DN00471A (hu) | 2009-06-29 | 2015-06-05 | Agios Pharmaceuticals Inc | |
| EP2448581B1 (en) * | 2009-06-29 | 2016-12-07 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
| US9221792B2 (en) | 2010-12-17 | 2015-12-29 | Agios Pharmaceuticals, Inc | N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators |
| JP6092118B2 (ja) | 2010-12-21 | 2017-03-08 | アジオス ファーマシューティカルズ， インコーポレイテッド | ニ環式ｐｋｍ２活性化剤 |
| TWI549947B (zh) | 2010-12-29 | 2016-09-21 | 阿吉歐斯製藥公司 | 治療化合物及組成物 |
| WO2012151440A1 (en) | 2011-05-03 | 2012-11-08 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia |
| ES2970938T3 (es) | 2011-05-03 | 2024-05-31 | Agios Pharmaceuticals Inc | Activadores de piruvato quinasa para uso en terapia |
| FR2976943B1 (fr) * | 2011-06-23 | 2013-07-12 | Metabolys | Derives de piperazine, leurs procedes de preparation et leurs utilisations dans le traitement de l'insulinoresistance |
| BR112015023279B1 (pt) * | 2013-03-13 | 2021-01-19 | Forma Therapeutics, Inc. | compostos para inibição de fasn |
| BR112015022226A2 (pt) | 2013-03-14 | 2017-07-18 | Celtaxsys Inc | inibidores de leucotrieno a4 hidrolase |
| WO2014139144A1 (en) | 2013-03-15 | 2014-09-18 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
| ES2634875T3 (es) | 2013-03-21 | 2017-09-29 | Merck Patent Gmbh | Derivados de piperazina como inhibidores de FASN |
| CA2989111C (en) | 2015-06-11 | 2023-10-03 | Agios Pharmaceuticals, Inc. | Methods of using pyruvate kinase activators |
| TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
| EP3873214A4 (en) | 2018-10-29 | 2022-07-13 | Forma Therapeutics, Inc. | SOLID FORMS OF (4-(2-FLUORO-4-(1-METHYL-1H-BENZO[D]IMIDAZOL-5-YL)BENZOYL)PIPERAZIN-1-YL)(1-HYDROXYCYCLOPROPYL)METHANONE |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992008709A1 (de) * | 1990-11-15 | 1992-05-29 | Pentapharm Ag | Meta-substituierte phenylalanin-derivate |
| ZA928276B (en) | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
| GB9208740D0 (en) * | 1992-04-23 | 1992-06-10 | Glaxo Group Ltd | Chemical compounds |
| DE4234295A1 (de) * | 1992-10-12 | 1994-04-14 | Thomae Gmbh Dr K | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| DE4302485A1 (de) * | 1993-01-29 | 1994-08-04 | Merck Patent Gmbh | Piperazinderivate |
| DK0817775T3 (da) | 1995-03-30 | 2001-11-19 | Pfizer | Quinazolinderivater |
| WO1997002245A1 (fr) * | 1995-07-06 | 1997-01-23 | Japan Tobacco Inc. | Derives de benzamidoxime et leur utilisation a des fins medicinales |
| CA2197364A1 (en) * | 1996-02-15 | 1997-08-16 | Toshikazu Suzuki | Phenol compound and process for preparing the same |
| CA2287292A1 (en) * | 1997-05-30 | 1998-12-03 | Takeda Chemical Industries, Ltd. | Sulfonamide derivatives, their production and use |
-
1997
- 1997-10-01 DE DE19743435A patent/DE19743435A1/de not_active Withdrawn
-
1998
- 1998-09-16 SK SK447-2000A patent/SK282799B6/sk unknown
- 1998-09-16 CN CN98809650A patent/CN1272107A/zh active Pending
- 1998-09-16 AU AU95407/98A patent/AU736080B2/en not_active Ceased
- 1998-09-16 CA CA002305568A patent/CA2305568A1/en not_active Abandoned
- 1998-09-16 US US09/509,729 patent/US6492368B1/en not_active Expired - Fee Related
- 1998-09-16 HU HU0004306A patent/HUP0004306A3/hu unknown
- 1998-09-16 KR KR1020007003536A patent/KR20010024386A/ko not_active Application Discontinuation
- 1998-09-16 RU RU2000110737/04A patent/RU2194044C2/ru not_active IP Right Cessation
- 1998-09-16 PL PL98339173A patent/PL339173A1/xx unknown
- 1998-09-16 JP JP2000513837A patent/JP2001518467A/ja active Pending
- 1998-09-16 AT AT98948982T patent/ATE243681T1/de not_active IP Right Cessation
- 1998-09-16 BR BR9812699-7A patent/BR9812699A/pt not_active IP Right Cessation
- 1998-09-16 DE DE59808842T patent/DE59808842D1/de not_active Expired - Fee Related
- 1998-09-16 EP EP98948982A patent/EP1025086B1/de not_active Expired - Lifetime
- 1998-09-16 WO PCT/EP1998/005898 patent/WO1999016751A1/de not_active Application Discontinuation
- 1998-09-16 ID IDW20000609A patent/ID24430A/id unknown
- 1998-09-29 AR ARP980104841A patent/AR017164A1/es not_active Application Discontinuation
- 1998-09-30 ZA ZA988937A patent/ZA988937B/xx unknown
-
2000
- 2000-03-31 NO NO20001687A patent/NO20001687D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2305568A1 (en) | 1999-04-08 |
| NO20001687L (no) | 2000-03-31 |
| AU9540798A (en) | 1999-04-23 |
| PL339173A1 (en) | 2000-12-04 |
| ATE243681T1 (de) | 2003-07-15 |
| NO20001687D0 (no) | 2000-03-31 |
| US6492368B1 (en) | 2002-12-10 |
| JP2001518467A (ja) | 2001-10-16 |
| DE19743435A1 (de) | 1999-04-08 |
| ZA988937B (en) | 1999-03-31 |
| WO1999016751A1 (de) | 1999-04-08 |
| EP1025086A1 (de) | 2000-08-09 |
| CN1272107A (zh) | 2000-11-01 |
| DE59808842D1 (de) | 2003-07-31 |
| BR9812699A (pt) | 2000-08-22 |
| HUP0004306A2 (hu) | 2001-11-28 |
| SK282799B6 (sk) | 2002-12-03 |
| AR017164A1 (es) | 2001-08-22 |
| RU2194044C2 (ru) | 2002-12-10 |
| ID24430A (id) | 2000-07-20 |
| EP1025086B1 (de) | 2003-06-25 |
| AU736080B2 (en) | 2001-07-26 |
| SK4472000A3 (en) | 2000-11-07 |
| KR20010024386A (ko) | 2001-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0004306A3 (en) | Benzamidine derivatives as factor xa inhibitors and process for their preparation | |
| EP0831800A4 (en) | ARYLSULFONYLAMINOBENZENE DERIVATIVES AND THEIR USE AS FACTOR Xa INHIBITORS | |
| AP9901556A0 (en) | Sulpponamide derivatives process for their preparation and their use as medicaments | |
| PL341008A1 (en) | Benzamidine derivatives | |
| PL341400A1 (en) | Derivatives of indole as inhibitors of factor xa | |
| PL330915A1 (en) | Phenylaniline derivatives as inhibitors of integrin | |
| HUP0001562A3 (en) | Aminotriazole derivatives process for their preparation and medicaments containing the same | |
| HUP0001848A3 (en) | 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors | |
| AU6230098A (en) | Isoquinolinone derivatives, process for preparing the same, and their use as phosphodiesterase inhibitors | |
| IL148698A0 (en) | INHIBITORS OF FACTOR Xa | |
| AU6157396A (en) | Bis-arylsulfonylaminobenzamide derivatives and the use there of as factor xa inhibitors | |
| AU4608696A (en) | N-substituted glycine derivatives as inhibitors of factor xa | |
| PL337645A1 (en) | Novel amidine derivatives and their application as thrombosin inhibitors | |
| IL143987A0 (en) | New amidinobenzylamine derivatives and their use as thrombin inhibitors | |
| ZA981976B (en) | Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation | |
| AU2540299A (en) | Products comprising fibrinogen for use in therapy | |
| AU4415797A (en) | New pde iv inhibitors: "bis-compounds" | |
| GR3035834T3 (en) | Benzoxazindione derivatives, process for their preparation and their use | |
| HUP0103569A3 (en) | New medicament and process for its preparation | |
| PL339493A1 (en) | Bis-ethers of 1-oxa, aza and thinaphtalen-2-ones as phospholamane inhibitors | |
| HUP0002727A3 (en) | Methods for reducing fibrinogen using benzotiophene derivatives | |
| AU8731798A (en) | Fused heterocyclic compounds and their use as kynurenine-3-hydroxylase inhibitors | |
| AU6230499A (en) | Method for preparing 2-chloropropionaldehyde and use of the same | |
| HUP9903870A3 (en) | Piperazine derivatives and process for the preparation thereof | |
| GB9700851D0 (en) | Dihydrophenanthrenone derivatives and process for their preparation |